Laminin and its Related Peptides for the Treatment of Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-6158|5|4|243-247

ISSN： 1568-0150

Source： Current Medicinal Chemistry - Central Nervous System Agents, Vol.5, Iss.4, 2005-01, pp. : 243-247

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peptides for Therapy and Diagnosis of Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 18, Iss. 6, 2012-02 ,pp. : 755-767

Bentham Science Publishers

Access to resources Recommend Favorite

Review of rivastigmine and its clinical applications in Alzheimer’s disease and related disorders

By Desai A.   Grossberg G.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 4, 2001-04 ,pp. : 653-666

Informa Healthcare

Access to resources Recommend Favorite

Alzheimer's Disease Related

By  

Current Bioactive Compounds, Vol. 2, Iss. 4, 2006-12 ,pp. : 503-503

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment strategies in Alzheimer's disease

By Levy R.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 204-205

Elsevier

Access to resources Recommend Favorite

Aripiprazole in the treatment of Alzheimer's disease

By De Deyn Peter Paul   Drenth Annemieke FJ   Kremer Berry P   Oude Voshaar Richard C   Van Dam Debby  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 4, 2013-03 ,pp. : 459-474

Informa Healthcare

Access to resources Recommend Favorite